Medications
Longevity and Age Management
Off-label prescribing priority research list drafted
Off-label prescribing, the practice of prescribing drugs for a purpose that the drug has not been approved for, may be commonplace and legal, but researchers say that in many cases there is simply not enough evidence to justify prescribing drugs off-label. ... Continue Reading
Higher risk of death associated with diabetes drug rosiglitazone
Study results have shown that seniors being treated with the diabetes drug rosiglitazone are more likely to die or develop heart failure than those treated with the similar drug pioglitazone. ... Continue Reading
Diuretics may increase diabetes risk by lowering blood potassium levels
New research suggests that depleted blood potassium levels could help to explain why people prescribed diuretics for the treatment of high blood pressure are at increased risk of type 2 diabetes. ... Continue Reading
Aspirin and other NSAIDs lower PSA levels
Researchers at Vanderbilt University have found that men who regularly take aspirin or other non-steroidal anti-inflammatory (NSAID) drugs have lower prostate specific antigen (PSA) levels than men who do not regularly use NSAIDs. ... Continue Reading
Statin dramatically cuts risk of heart attack and stroke in people with normal cholesterol
A large study of people with normal cholesterol levels has found that the statin drug rosuvastatin can dramatically reduce their risk of heart attack and stroke. ... Continue Reading
Half of women fail to finish tamoxifen course
A British study has revealed that half of women prescribed tamoxifen fail to finish the recommended 5-year-long course of treatment. ... Continue Reading
More children being prescribed drugs for obesity-related health problems
Results of a new study have revealed that more and more children are being prescribed drugs to treat obesity-related problems such as diabetes, hypertension, and high cholesterol. ... Continue Reading
Statins reduce risk of dying from pneumonia
Study results suggest that people who are taking statins are more likely to survive if they are hospitalized with pneumonia. ... Continue Reading
Epilepsy drug may be useful in the treatment of Alzheimer’s disease
New research suggests that the epilepsy drug valproic acid may be beneficial to people with Alzheimer’s disease, as long as it is given in the early stages of the neurodegenerative disease. ... Continue Reading
Anti-obesity drug suspended in Europe
The European Medicines Agency (EMEA) has advised doctors not to prescribe the anti-obesity drug rimonabant, also known as Acomplia, because of concerns that it causes psychiatric problems. ... Continue Reading
Subscribe to the EBN
The Longevity Newsletter
